Abstract
This study used a modified version of the Behavioral Model for Vulnerable Populations to examine the predisposing, enabling, and need factors associated with detectable viral load (VL). HIV status was measured using saliva and confirmed by blood. Of 797 persons enrolled, 193 were HIV positive and provided VL counts. A hierarchical multivariate logistic regression approach demonstrated that the predisposing factors of homelessness and recent substance abuse, particularly methamphetamine abuse, had a negative association with VL. The negative association of homelessness on VL was weakened with the introduction of enabling and need utilization factors. Mediation analysis indicated homelessness and HIV medication taking significantly associated with methamphetamine use as a predictor of detectable viral load. Guided policy to address substance abuse among those who are HIV positive is needed to improve biological outcomes.
Similar content being viewed by others
References
Aidala, A., Cross, J. E., Stall, R., Harre, D., & Sumartojo, E. (2005). Housing status and HIV risk behaviors: Implications for prevention and policy. AIDS and Behavior, 9(3), 251–265.
Anderson, R., Bozzette, S., Shapiro, M., St. Clair, P., Morton, S., Crystal, S., Goldman, D., Wenger, N., Gifford, A, Leibowitz, A., Asch, S., Berry, S., Nakazono, T., Heslin, K., Cunningham, W., & the HCSUS Consortium (2000). Access of vulnerable groups to antiretroviral therapy among persons in care for HIV disease in the United States. Health Services Research, 35(2), 389–416.
Arnsten, J., Demas, P., Grant, R., Gourevitch, M., Farzadegan, H., Howard, A., & Schoenbaum, E. (2002). Impact of active drug use on antiretroviral therapy adherence and viral suppression in HIV-infected drug users. Journal of General Internal Medicine, 17(5), 377–381.
Barkin, S. L., Balkrishan, R., Manuel, J., Andersen, R. M., & Gelberg, L. (2003). Health care utilization among homeless adolescents and young adults. Journal of Adolescent Health, 32(4), 253–256.
Centers for Disease Control and Prevention, Factsheet, HIV/AIDS Among African Americans (2006). Atlanta: CDC.
Crum, N. F., Riffenburgh, R. H., Wegner, S., Agan, B. K., Tasker, S. A., Spooner, K. M., Armstrong, A. W., Fraser, s., Wallace, M. R., & Triservice AIDS Clinical Consortium (2006). Comparisons of causes of death and mortality rates among HIV-infected persons; analysis of the pre-, early, and late HAART (highly active antiretroviral therapy) eras. Journal of Acquired Immune Deficiency Syndrome, 41(2), 194–200.
Culhane, D. P., Gollub, E., Kuhn, R., & Shpaner, M. (2001). The co-occurrence of AIDS and homelessness: Results from the integration of administrative databases for AIDS surveillance and public shelter utilisation in Philadelphia. Journal of Epidemiology and Community Health, 55(7), 515–520.
Cunningham, W. E., Hays, R. D., Williams, K. W., Beck, K. C., Dixon, W. J., & Shapiro, M. F. (1995). Access to medical care and health-related quality of life for low-income persons with symptomatic human immunodeficiency virus. Medical Care, 33(7), 739–754.
Cunningham, W., Hays, R., Ettl, M., Dixon, W., Liu, C.-C., Beck, K., & Shapiro, M. (1998). The prospective effect of access to medical care on health-related quality-of-life outcomes in patients with symptomatic HIV disease. Medical Care, 36(3), 295–306.
Cunningham, W. E., Andersen, R. M., Katz, M. H., Stein, M. D., Turner, B. J., Crystal, S., Zierler, S., Kuromiya, K., Morton, S. C., St. Clair, P., Bozzette, S. A., & Shapiro, M. F. (1999). The impact of competing subsistence needs and barriers on access to medical care for persons with human immunodefiency virus receiving care in the United States. Medical Care, 37(12), 1270–1281.
Cunningham, W. E., Hays, R. D., Duan, N., Andersen, R., Nakazono, T. T., Bozzette, S. A., & Shapiro, M. F. (2005). The effect of socioeconomic status on the survival of people receiving care for HIV infection in the United States. Journal of Health Care for the Poor and Underserved, 16(4), 655–676.
Derogatis, L. R. (2000). The brief symptom inventory 18: Administration, scoring and procedures manual. Minneapolis, MN: NCS Pearson.
Diaz, T., Chu, S. Y., Buehler, J. W., Boyd, D., Checko, P. J., Conti, L., Davidson, A. J., Hermann, P., Herr, M., Levy, A. et al. (1994). Socioeconomic differences among people with AIDS: Results from a multistate surveillance project. American Journal of Preventive Medicine, 10(4), 217–222.
Duran, S., Spire, B., Raffi, F., Walter, V., Bouhour, D., Journot, V., Cailleton, V., Leport, C., Moatti, J. P., & the APROCO Cohort Study Group (2001). Self-reported symptoms after initiation of protease inhibitor in HIV-infected patients and their impact on adherence to HAART. HIV Clinical Trials, 2(1), 38–45.
Gavrilin, M. A., Mathes, L. E., & Podell, M. (2002). Methamphetamine enhances cell-associated feline immunodeficiency virus replication in astrocytes. Journal of Neurovirology, 8, 240–249.
Gelberg, L., Andersen, R. M., & Leake, B. D. (2000). The behavioral model for vulnerable populations: Application to medical care use and outcomes for homeless people. Health Services Research, 34(6), 1273–1302.
Gordon, A. J., McGinnis, K. A., Conigliaro, J., Rodriguez-Barradas, M. C., Rabeneck, L., Justice, A. C., & VACS-3 Project Team (2006). Associations between alcohol use and homelessness with healthcare utilization among human immunodeficiency virus-infected veterans. Medical Care, 44(8 Suppl 2), S37–S43.
Halkitis, P., Kutnick, A., & Slater, S. (2005). The social realities of adherence to protease inhibitor regimens: Substance use, health care and psychological states. Journal of Health Psychology, 10(4), 545–558.
Heckathorn, D. (2002). Respondent-driven sampling II: Deriving valid population estimates from chain-referral samples of hidden populations. Social Problems, 49, 11–34.
Heckathorn, D., Broadhead, R., Antony, D., & Weakliem, D. (1999). AIDS and social networks: Prevention through network mobilization, Social Focus, 32, 159–179.
Heckathorn, D. D., & Volz, E. (2006). Respondent-driven sampling analysis tool (RDSAT) 5.6.0. Ithaca, NY: Department of Sociology, Cornell University.
Herndon, B., Asch, S. M., Kilbourne, A. M., Wang, M., Lee, M., Wenzel, S. L., Andersen, R., & Gelberg, L. (2003). Prevalence and predictors of HIV testing among a probability sample of homeless women in Los Angeles County. Public Health Reports, 118(3), 261–269.
Ho, D., Neuman, A., Perelson, A., Chen, W., Leonard, J., & Markowitz, M. (1995). Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature, 373, 123–126.
Katz, M., Cunningham, W., Flieshman, J., Anderson, R., Kellogg, T., Bozzette, S., & Shapiro, M. (2001). Effect of case management on unmet needs and utilization of medical care and medications among HIV-infected persons. Annals of Internal Medicine, 135(8), 557–565.
Kim, T., Kertesz, S., Horton, N., Tibbets, N., & Samet, J. (2006). Episodic homelessness and healthcare utilization in a prospective cohort of HIV-infected persons with alcohol problems. BMC Health Services Research, 6(19), 1–10.
King, W. D., Wong, M. D., Shapiro, M. F., Landon, B. E., & Cunningham, W. E. (2004). Does racial concordance between HIV-positive patients and their physicians affect the time to receipt of protease inhibitors? Journal of General Internal Medicine, 19(11), 1146–1153.
Knowlton, A., Hoover, D., Chung, S., Celentano, D., Vlahov, D., & Latkin, C. (2001). Access to medical care and service utilization among injection drug users with HIV/AIDS. Drug and Alcohol Dependence, 64(1), 55–62.
Krueger, L. E., Wood, R. W., Diehr, P. H., & Maxwell, C. L. (1990). Poverty and HIV seropositivity: The poor are more likely to be infected. AIDS Aug, 4(8), 811–814.
Kushel, M., Colfax, G., Ragland, K., Heineman, A., Palacio, H., & Bangsberg, D. R. (2006). Case management is associated with improved antiretroviral adherence and CD4 cell counts in homeless and marginally housed individuals with HIV infection. Clinical Infectious Diseases, 43, 234–242.
Kushel, M., Vittinghoff, E., & Haas, J. (2001). Factors associated with the health care utilization of homeless persons. Journal of the American Medical Association, 285, 200–206.
Lewis, J. H., Andersen, R. M., & Gelberg, L. (2003). Health care for homeless women. Journal of General Internal Medicine, 18(11), 921–928.
Little, S., Holte, S., Routy, J.-P., Daar, E., Markowitz, M., Collier, A., Koup, R., Mellors, J., Connick, E., Conway, B., & Kilby, M. (2002). Antiretroviral drug resistance among patients recently infected with HIV. New England Journal of Medicine, 347, 385–394.
Low-Beer, S., Yip, B., O’Shaughnessey, M., Hogg, R., & Montaner, J. (2000). Adherence to triple therapy and viral load response. Journal of Acquired Immune Deficiency Syndrome, 23, 360–361.
Lucas, G., Cheever, L., & Chaisson, R. (2001). Detrimental effects of continued illicit drug use on the treatment of HIV-1 infection. Journal of Acquired Immune Deficiency Syndrome, 27, 251–259.
Markowitz, D., Mohri, H., Mehandru, S., Shet, A., Kalyanaraman, L. B. R., Kim, A., Chung, C., Jean-Pierre, P., Horowitz, A., La Mar, M., Wrin, T., Parkin, N., Poles, M., Petropoulos, C., Mullen, M., Boden, D., & Ho, D. D. (2005). Infection with multidrug resistant, dual-tropic HIV-1 and rapid progression to AIDS, a case report. The Lancet, 365, 1031–1038.
Martens, W. (2001). A review of physical and mental health in homeless persons. Public Health Review, 29, 13–33.
Martin, J. L., Wiley, J., & Osmond, D. (2003). Social networks and unobserved heterogeneity in risk for AIDS. Population Research and Policy Review, 22, 65–90.
Moss, A., Hahn, J., Perry, S., Charlebois, E., Guzman, D., Clark, R., & Bangsberg, D. (2004). Adherence to highly active antiretroviral therapy in the homeless population in San Francisco: A prospective study. Clinical Infectious Diseases, 39, 1190–1198.
O’Connell, J., Braitstein, P., & Hogg, R. (2003). Age, adherence and injection drug use predict virological suppression among men and women enrolled in a population-based antiretroviral drug treatment programme. Antiretroviral Therapy, 8, 569–576.
Pastori, C., Weiser, B., Barassi, C., Uberti-Foppa, C., Ghezzi, S., Longhi, R., Calori, G., Burger, H., Kemal, K., Poli, G., Lazzarin, A., & Lopalco, L. (2006). Long-lasting CCR5 internalization by antibodies in a subset of long-term nonprogressors: A possible protective effect against disease progression. Blood, 107(12), 4825–4833.
Pulvirenti, J., Glowacki, R., & Muppiddi, U. (2003). Hospitalized HIV-infected patients in the HAART era: A view from the inner city. AIDS Patient Care STDS, 17, 565–573.
Rameriz-Valles, J., Heckethorn, D., Vazquez, R., Diaz, R., & Campbell, R. T. (2005). From networks to populations: The development and application of respondent-driven sampling among IDUs and Latino gay men. AIDS and Behavior, 9(4), 387–402.
Reback, C. J., Larkins, S., & Shoptaw, S. (2003). Methamphetamine abuse as a barrier to HIV medication adherence among gay and bisexual men. AIDS Care, 15(6), 775–785.
Riley, E. D., Bangsberg, D. R., Guzman, D., Perry, S., & Moss, A. R. (2005). Antiretroviral therapy, hepatitis C virus, and AIDS mortality among San Francisco’s homeless and marginally housed. Journal of Acquired Immune Deficiency Syndrome, 38(2), 191–195.
Strathdee, S., Palepu, A., Cornelisse, P., Yip, B., O’Shaughnessy, M., Montaner, J., Schechter, M., & Hogg, R. (1998). Barriers to use of free antiretroviral therapy in injection drug users. Journal of the American Medical Association, 280, 547–549.
Stein, J. A., Andersen, R. M., Koegel, P., & Gelberg, L. (2000). Predicting health services utilization among homeless adults: A prospective analysis. Journal of Health Care for the Poor and Underserved, 11(2), 212–230.
Turner, B. J., Fleishman, J. A., Wenger, N., London, A. S., Burnam, M. A., & Shapiro, M. F. (2001). Effects of drug abuse and mental disorders on use and type of antiretroviral therapy in HIV-infected persons. Journal of General Internal Medicine, 16, 625–633.
U.S. Department of Health and Human Services, Health Resources and Services Adminsitration (DHHS/HRSA) (1999). Principles of Practice: A Clinical Resource Guide for Health Care for the Homeless Programs, Bureau of Primary Health Care, March 1, PAL 99–12.
Waldrop-Valverde, D., & Valverde, E. (2005). Homelessness and psychological distress as contributors to antiretroviral nonadherence in HIV-positive injecting drug users. AIDS, Patient Care and STDs, 19(5), 326–334.
Yorke, J. A., Hethcote, H. W., & Nold, A. (1978). Dynamics and control of the transmission of gonorrhea. Sexually Transmitted Diseases, 5(2), 51–56.
Acknowledgments
The research team would like to thank Dr. Ronald Andersen for his advice and expertise in the adaptation of the Andersen/Gelberg model and the following individuals for their assistance in the development of this manuscript: Mr. Gregory D. Victorianne; Ms Uyen Kao. This project was funded by National Institute of Drug Abuse U01DA17394 (Shoptaw, PI); Minority supplement (Shoptaw PI./King).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
King, W.D., Larkins, S., Hucks-Ortiz, C. et al. Factors Associated with HIV Viral Load in a Respondent Driven Sample in Los Angeles. AIDS Behav 13, 145–153 (2009). https://doi.org/10.1007/s10461-007-9337-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10461-007-9337-1